Jennison Associates
WST icon

Jennison Associates’s West Pharmaceutical WST Stock Holding History

Jennison Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,593
Closed -$15M – 641
2025
Q4 		$15M Buy
54,593
+17,363
+47% +$4.75M 0.01% 365
2025
Q3 		$9.77M Buy
+37,230
New +$9.05M 0.01% 374
2021
Q3 		– Sell
-4,403
Closed -$1.58M – 735
2021
Q2 		$1.58M Sell
4,403
-12,941
-75% -$4.28M ﹤0.01% 577
2021
Q1 		$4.89M Sell
17,344
-731
-4% -$209K ﹤0.01% 475
2020
Q4 		$5.12M Sell
18,075
-508
-3% -$143K ﹤0.01% 454
2020
Q3 		$5.11M Buy
18,583
+12,130
+188% +$3.21M ﹤0.01% 437
2020
Q2 		$1.47M Buy
+6,453
New +$1.27M ﹤0.01% 491
2020
Q1 		– Sell
-4,123
Closed -$620K – 710
2019
Q4 		$620K Buy
+4,123
New +$600K ﹤0.01% 577
2018
Q1 		– Sell
-354,164
Closed -$34.9M – 704
2017
Q4 		$34.9M Sell
354,164
-313,859
-47% -$30.8M 0.03% 308
2017
Q3 		$64.3M Buy
668,023
+236,022
+55% +$21.4M 0.07% 235
2017
Q2 		$40.8M Sell
432,001
-44,310
-9% -$4.08M 0.04% 295
2017
Q1 		$38.9M Sell
476,311
-3,825
-0.8% -$320K 0.04% 315
2016
Q4 		$40.7M Buy
+480,136
New +$37.8M 0.05% 297
2014
Q3 		– Sell
-13,662
Closed -$576K – 758
2014
Q2 		$576K Sell
13,662
-2
-0% -$86 ﹤0.01% 677
2014
Q1 		$602K Sell
13,664
-178
-1% -$8.38K ﹤0.01% 680
2013
Q4 		$679K Sell
13,842
-8,174
-37% -$383K ﹤0.01% 635
2013
Q3 		$906K Sell
22,016
-350
-2% -$13.4K ﹤0.01% 618
2013
Q2 		$786K Buy
+22,366
New +$736K ﹤0.01% 608

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates's WST Position: Q1 2026 in Review

Jennison Associates sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 54,593 shares — an estimated $15M sold.

Jennison Associates first reported a position in WST in Q2 2013 and held it in 18 quarters. The position peaked at $64.3M in Q3 2017. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Jennison Associates reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Jennison Associates sold 54,593 West Pharmaceutical shares in Q1 2026, an estimated $15M.
  • Jennison Associates first reported a position in West Pharmaceutical in Q2 2013 and held it in 18 quarters.
  • Jennison Associates's West Pharmaceutical position peaked at $64.3M in Q3 2017.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.